Cytek Biosciences Announces $50 Million Stock Repurchase Program

June 6, 2024

https://www.globenewswire.com/news-release/2024/06/06/2894624/0/en/Cytek-Biosciences-Announces-50-Million-Stock-Repurchase-Program.html

FREMONT, Calif., June 06, 2024 (GLOBE NEWSWIRE) — Cytek Biosciences, Inc. (Nasdaq:CTKB), a leading cell analysis solutions company, today announced that its Board of Directors has approved the repurchase of up to an aggregate of $50 million of its common stock, subject to compliance with applicable law. The Company’s common stock is listed on The Nasdaq Global Select Market under the symbol “CTKB”. The repurchase program will continue until December 31, 2024 unless extended or shortened by the Board of Directors.

Read more at globenewswire.com

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.